Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
5.43
Dollar change
-0.16
Percentage change
-2.86
%
Index- P/E- EPS (ttm)-1.80 Insider Own37.03% Shs Outstand7.64M Perf Week-0.37%
Market Cap43.42M Forward P/E- EPS next Y-1.24 Insider Trans-0.12% Shs Float5.03M Perf Month-17.10%
Enterprise Value41.03M PEG- EPS next Q-0.40 Inst Own12.70% Short Float5.37% Perf Quarter-10.40%
Income-14.16M P/S1.46 EPS this Y-8.43% Inst Trans-1.57% Short Ratio4.68 Perf Half Y3.63%
Sales29.84M P/B- EPS next Y28.31% ROA-66.70% Short Interest0.27M Perf YTD21.07%
Book/sh-0.14 P/C3.29 EPS next 5Y26.94% ROE-337.84% 52W High19.49 -72.14% Perf Year-68.38%
Cash/sh1.65 P/FCF- EPS past 3/5Y28.60% 41.43% ROIC-152.72% 52W Low4.16 30.53% Perf 3Y3.61%
Dividend Est.- EV/EBITDA- Sales past 3/5Y66.55% 60.15% Gross Margin86.04% Volatility8.37% 11.42% Perf 5Y-87.34%
Dividend TTM- EV/Sales1.38 EPS Y/Y TTM1.62% Oper. Margin-44.52% ATR (14)0.59 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.33 Sales Y/Y TTM27.90% Profit Margin-47.46% RSI (14)42.98 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.43 EPS Q/Q-30.70% SMA20-15.83% Beta0.54 Target Price19.68
Payout- Debt/Eq- Sales Q/Q32.58% SMA50-3.18% Rel Volume0.72 Prev Close5.59
Employees73 LT Debt/Eq- EarningsNov 05 AMC SMA200-1.91% Avg Volume57.75K Price5.43
IPOJun 22, 2018 Option/ShortNo / Yes EPS/Sales Surpr.0.00% 10.18% Trades Volume41,406 Change-2.86%
Date Action Analyst Rating Change Price Target Change
Aug-14-20Upgrade BTIG Research Neutral → Buy $3.50
Nov-14-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-26-19Resumed Cantor Fitzgerald Neutral $9
May-30-19Downgrade Cantor Fitzgerald Overweight → Neutral
May-15-19Downgrade BTIG Research Buy → Neutral
May-09-19Initiated Noble Capital Markets Outperform
Sep-21-18Initiated Cantor Fitzgerald Overweight
Jan-21-26 08:00AM
Jan-20-26 08:00AM
Dec-02-25 08:00AM
Nov-10-25 04:05PM
Nov-05-25 06:35PM
04:05PM Loading…
04:05PM
Nov-04-25 08:50AM
Oct-29-25 10:00AM
Oct-23-25 08:11AM
Oct-03-25 04:05PM
Sep-30-25 08:00AM
Sep-29-25 08:00AM
Sep-22-25 08:00AM
Sep-10-25 04:05PM
Sep-05-25 08:00AM
08:00AM Loading…
Sep-04-25 08:00AM
Sep-03-25 08:00AM
Sep-02-25 08:00AM
Aug-12-25 08:00AM
Aug-06-25 05:35PM
04:05PM
Aug-05-25 05:55PM
10:35AM
08:00AM
Jul-23-25 08:00AM
Jul-22-25 04:05PM
Jul-14-25 10:01AM
May-09-25 11:00AM
May-07-25 11:18PM
11:16PM
06:15PM Loading…
06:15PM
04:05PM
01:36PM
May-05-25 04:48AM
May-02-25 08:00AM
May-01-25 08:00AM
Apr-30-25 08:00AM
Apr-17-25 08:00AM
Apr-16-25 08:00AM
Apr-03-25 08:00AM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
Mar-13-25 03:11AM
Mar-12-25 05:15PM
04:05PM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-27-25 08:00AM
Feb-19-25 08:00AM
Feb-18-25 07:59AM
Feb-06-25 08:00AM
Feb-04-25 08:00AM
Jan-07-25 08:00AM
Jan-02-25 11:09AM
Dec-17-24 04:05PM
04:05PM
Nov-20-24 08:00AM
Nov-19-24 08:00AM
Nov-14-24 08:00AM
02:16AM
Nov-13-24 05:15PM
04:01PM
Nov-12-24 04:01PM
Nov-11-24 04:13AM
Nov-08-24 04:01PM
Oct-23-24 08:00AM
Oct-22-24 05:51PM
10:20AM
Oct-14-24 08:00AM
Oct-09-24 05:19PM
Sep-26-24 08:00AM
Sep-24-24 08:00AM
Sep-10-24 08:00AM
Sep-04-24 08:00AM
02:00AM
Aug-08-24 08:00AM
Aug-07-24 05:40PM
04:01PM
Aug-02-24 04:05PM
Aug-01-24 08:00AM
Jul-31-24 08:00AM
Jun-25-24 08:00AM
Jun-11-24 08:00AM
Jun-06-24 01:00PM
08:00AM
Jun-03-24 08:30AM
May-30-24 09:55AM
May-29-24 09:00AM
May-14-24 09:55AM
08:50AM
May-09-24 02:42PM
03:43AM
May-08-24 09:56PM
05:45PM
04:05PM
May-03-24 04:05PM
May-01-24 08:04AM
Apr-30-24 08:00AM
Apr-08-24 08:30AM
Apr-02-24 08:00AM
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lev Joshua S.Chief Financial OfficerDec 04 '25Sale5.052,50012,62521,667Dec 05 04:15 PM
Goldberger Daniel SChief Executive OfficerDec 02 '25Buy4.841,0004,840292,565Dec 03 07:00 AM
Lev Joshua S.Chief Financial OfficerNov 12 '25Sale6.182,16613,38623,667Nov 14 04:33 PM
Errico Thomas J.DirectorAug 11 '25Buy4.4715,00067,050281,401Aug 13 06:05 AM
Goldberger Daniel SChief Executive OfficerAug 11 '25Buy4.231,0004,230291,565Aug 12 06:05 AM
GANDOLFO JOHN PDirectorMay 23 '25Buy5.011,8009,01869,087May 27 09:27 AM
Errico Thomas J.DirectorMay 12 '25Buy4.7710,00047,735266,401May 13 02:00 PM
Theofilos Charles SteveDirectorMar 25 '25Proposed Sale7.3965,000480,675Mar 25 10:26 AM
Goldberger Daniel SChief Executive OfficerMar 17 '25Buy8.591,0008,590290,565Mar 18 10:52 AM
Errico Thomas J.DirectorMar 17 '25Buy8.106,00048,585256,401Mar 17 08:00 PM
Last Close
Feb 13  •  04:00PM ET
4.67
Dollar change
+0.30
Percentage change
6.86
%
KRMD KORU Medical Systems Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.08 Insider Own5.69% Shs Outstand46.29M Perf Week-5.08%
Market Cap216.33M Forward P/E- EPS next Y-0.02 Insider Trans0.00% Shs Float43.69M Perf Month-16.16%
Enterprise Value211.54M PEG- EPS next Q-0.02 Inst Own56.88% Short Float1.69% Perf Quarter23.54%
Income-3.71M P/S5.54 EPS this Y49.23% Inst Trans-0.78% Short Ratio3.53 Perf Half Y13.35%
Sales39.07M P/B13.13 EPS next Y75.76% ROA-13.62% Short Interest0.74M Perf YTD-19.62%
Book/sh0.36 P/C25.57 EPS next 5Y- ROE-21.71% 52W High6.61 -29.33% Perf Year-1.68%
Cash/sh0.18 P/FCF- EPS past 3/5Y-8.83% - ROIC-19.26% 52W Low1.86 151.08% Perf 3Y21.61%
Dividend Est.- EV/EBITDA- Sales past 3/5Y12.72% 7.75% Gross Margin60.16% Volatility6.39% 5.67% Perf 5Y6.86%
Dividend TTM- EV/Sales5.41 EPS Y/Y TTM69.19% Oper. Margin-10.28% ATR (14)0.31 Perf 10Y961.36%
Dividend Ex-Date- Quick Ratio1.92 Sales Y/Y TTM22.12% Profit Margin-9.50% RSI (14)36.80 Recom1.40
Dividend Gr. 3/5Y- - Current Ratio2.48 EPS Q/Q51.30% SMA20-10.95% Beta0.49 Target Price6.60
Payout- Debt/Eq0.22 Sales Q/Q27.17% SMA50-16.35% Rel Volume1.11 Prev Close4.37
Employees80 LT Debt/Eq0.17 EarningsNov 12 AMC SMA20010.99% Avg Volume209.48K Price4.67
IPOApr 05, 1994 Option/ShortYes / Yes EPS/Sales Surpr.18.03% 7.70% Trades Volume231,661 Change6.86%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Downgrade Piper Sandler Overweight → Neutral $4.50
Jul-25-24Resumed B. Riley Securities Buy $4
Sep-07-23Initiated Lake Street Buy $4
Sep-07-23Initiated B. Riley Securities Buy $4.50
Nov-10-22Upgrade Piper Sandler Neutral → Overweight $3 → $3.50
Nov-10-22Upgrade Canaccord Genuity Hold → Buy $3 → $4
Jan-26-21Downgrade Piper Sandler Overweight → Neutral $9 → $4.50
Jan-26-21Downgrade Canaccord Genuity Buy → Hold $5
Aug-10-20Initiated H.C. Wainwright Buy $16
Jul-16-20Initiated Canaccord Genuity Buy $13
Feb-12-26 09:35AM
Feb-11-26 05:15PM
Feb-03-26 07:13AM
Jan-30-26 07:01AM
Jan-29-26 04:05PM
12:00PM Loading…
Jan-21-26 12:00PM
Jan-12-26 08:00AM
Jan-09-26 09:18AM
Jan-07-26 12:24PM
Jan-05-26 07:00AM
Dec-31-25 10:30AM
Dec-30-25 04:05PM
Dec-22-25 07:51AM
Dec-19-25 08:41AM
Dec-18-25 08:28AM
04:05PM Loading…
Dec-16-25 04:05PM
Nov-17-25 04:05PM
Nov-13-25 08:00AM
12:02AM
Nov-12-25 06:00PM
04:05PM
Nov-11-25 07:32AM
Nov-07-25 07:15AM
Nov-04-25 04:05PM
Oct-22-25 04:05PM
Sep-18-25 08:00AM
Aug-28-25 12:00PM
Aug-06-25 06:40PM
04:05PM
Aug-05-25 07:05PM
10:29AM Loading…
10:29AM
Aug-01-25 04:55PM
Jul-31-25 07:45AM
Jul-30-25 04:05PM
Jul-16-25 04:05PM
Jul-07-25 04:05PM
Jun-11-25 04:05PM
May-08-25 03:32AM
May-07-25 05:50PM
04:05PM
Apr-16-25 04:05PM
Mar-13-25 03:08AM
Mar-12-25 04:05PM
Feb-19-25 04:05PM
Feb-14-25 01:01PM
Feb-06-25 04:05PM
Jan-30-25 04:05PM
Jan-14-25 04:06PM
Nov-25-24 04:05PM
Nov-15-24 07:16AM
Nov-14-24 02:16AM
Nov-13-24 04:05PM
Nov-06-24 04:05PM
Oct-31-24 04:03PM
Oct-23-24 04:05PM
Oct-09-24 05:19PM
Sep-05-24 07:00AM
Aug-07-24 04:05PM
Jul-25-24 04:05PM
Jul-24-24 04:05PM
Jul-17-24 04:05PM
Jul-03-24 12:27PM
Jul-02-24 07:00AM
Jun-05-24 09:00AM
Jun-04-24 04:03PM
May-14-24 04:05PM
May-02-24 10:29AM
03:39AM
May-01-24 06:06PM
04:05PM
Apr-17-24 07:00AM
Apr-11-24 04:05PM
Mar-18-24 05:24PM
Mar-13-24 04:05PM
Mar-12-24 08:22AM
Mar-11-24 04:05PM
Mar-06-24 07:00AM
Feb-21-24 07:00AM
Nov-29-23 07:00AM
Nov-28-23 08:00AM
Nov-09-23 10:04AM
Nov-08-23 06:11PM
04:10PM
04:08PM
04:05PM
Nov-07-23 04:05PM
Nov-02-23 04:05PM
Oct-25-23 04:05PM
Oct-05-23 07:05AM
Oct-04-23 04:05PM
Sep-15-23 08:05AM
Aug-09-23 04:05PM
Aug-08-23 04:05PM
Aug-02-23 05:15PM
Jul-31-23 04:05PM
Jul-27-23 04:05PM
Jul-10-23 07:01AM
Jun-27-23 07:05AM
May-09-23 03:15PM
May-04-23 04:01PM
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tharby Linda MOfficerApr 21 '25Proposed Sale2.2023,58751,955Apr 21 05:15 PM
Tharby Linda MChief Executive OfficerMar 17 '25Option Exercise0.0015,96801,085,411Mar 21 04:35 PM
Miller Kenneth EChief Commercial OfficerMar 17 '25Option Exercise0.005,89305,893Mar 21 04:32 PM
Adams Thomas EdwardChief Financial OfficerMar 17 '25Option Exercise0.005,40405,404Mar 21 04:30 PM
Pazdan ChristopherOfficerMar 19 '25Proposed Sale2.8414,49041,157Mar 19 04:40 PM
Tharby Linda MOfficerMar 19 '25Proposed Sale2.8329,81384,502Mar 19 04:32 PM
Tharby Linda MOfficerMar 17 '25Proposed Sale2.898,84825,547Mar 17 04:51 PM